<table id="table5" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5: Drug Interactions that Result in Increased Concentrations of the Concomitant Drug</caption>
<col align="left" valign="top" width="50%"></col>
<col align="left" valign="middle" width="50%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule">Drug Class or Drug Name</th>
<th stylecode="Rrule">Clinical Recommendations</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Digoxin (P-gp substrate)</td>
<td stylecode="Rrule">Measure serum digoxin concentrations before initiating CERDELGA.  Reduce digoxin dose by 30% and continue monitoring.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="underline">Other P-gp substrates</content>
<br/>(e.g., phenytoin, colchicine, dabigatran etexilate)</td>
<td rowspan="2" stylecode="Rrule">Monitor therapeutic drug concentrations, as indicated, or consider reducing the dosage of the concomitant drug and titrate to clinical effect.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="underline">CYP2D6 substrates</content>
<list listtype="unordered" stylecode="Disc">
<item>Metoprolol;</item>
<item>tricyclic antidepressants (e.g., nortriptyline, amitriptyline, imipramine);</item>
<item>phenothiazines (e.g., perphenazine, chloropromazine).</item>
</list>
</td>
</tr>
</tbody>
</table>